<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font24 { font-size : 24; } .font10 { font-size : 10; } .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font30 { font-size : 30; } .font14 { font-size : 14; } .font15 { font-size : 15; }</style>
 <body>
  <p>
   <span class="font30">the </span>
   <span class="font24">and </span>
   <span class="font15">&amp;amp; </span>
   <span class="font14">(). </span>
   <span class="font14">The </span>
   <span class="font13">al., </span>
   <span class="font13">binding </span>
   <span class="font13">for </span>
   <span class="font13">drugs </span>
   <span class="font12">(), </span>
   <span class="font12">Journal </span>
   <span class="font12">that </span>
   <span class="font12">were </span>
   <span class="font12">{background </span>
   <span class="font12">could </span>
   <span class="font12">with </span>
   <span class="font12">Yes </span>
   <span class="font12">coronavirus </span>
   <span class="font12">are </span>
   <span class="font12">spike </span>
   <span class="font11">protein </span>
   <span class="font11">SARS-CoV </span>
   <span class="font11">A., </span>
   <span class="font11">margin </span>
   <span class="font11">was </span>
   <span class="font11">{border-style </span>
   <span class="font11">chloroquine </span>
   <span class="font11">px;} </span>
   <span class="font11">#ffffff;} </span>
   <span class="font11">Biomolecular </span>
   <span class="font11">Chloroquine </span>
   <span class="font11">LEU, </span>
   <span class="font11">Lopinavir </span>
   <span class="font11">Structure </span>
   <span class="font11">./.. </span>
   <span class="font11">glycoprotein/ACE- </span>
   <span class="font11">predicted </span>
   <span class="font11">remdesivir, </span>
   <span class="font11">human </span>
   <span class="font11">using </span>
   <span class="font11">while </span>
   <span class="font11">molecular </span>
   <span class="font11">(log </span>
   <span class="font11">had </span>
   <span class="font11">lopinavir, </span>
   <span class="font11">through </span>
   <span class="font10">Dynamics. </span>
   <span class="font10">J., </span>
   <span class="font10">Oseltamivir </span>
   <span class="font10">drug </span>
   <span class="font10">has </span>
   <span class="font10">have </span>
   <span class="font10">protease </span>
   <span class="font10">viral </span>
   <span class="font10">PHE, </span>
   <span class="font10">Table </span>
   <span class="font10">affinities </span>
   <span class="font10">also </span>
   <span class="font10">azithromycin, </span>
   <span class="font10">been </span>
   <span class="font10">complex </span>
   <span class="font10">entry </span>
   <span class="font10">kinase </span>
   <span class="font10">lysosomal </span>
   <span class="font10">showed </span>
   <span class="font10">Figure </span>
   <span class="font10">However, </span>
   <span class="font10">Molecular </span>
   <span class="font10">S., </span>
   <span class="font10">against </span>
   <span class="font10">all </span>
   <span class="font10">docking </span>
   <span class="font10">enzyme </span>
   <span class="font10">permeability </span>
   <span class="font10">respiratory </span>
   <span class="font10">ribavirin </span>
   <span class="font10">Azithromycin </span>
   <span class="font10">M., </span>
   <span class="font10">Remdesivir </span>
   <span class="font10">Ribavirin </span>
   <span class="font10">free </span>
   <span class="font10">highest </span>
   <span class="font10">into </span>
   <span class="font10">novel </span>
   <span class="font10">properties </span>
   <span class="font10">px; </span>
   <span class="font10">silico </span>
   <span class="font10">{font-family </span>
   <span class="font10">D., </span>
   <span class="font10">Docking </span>
   <span class="font10">HIS </span>
   <span class="font10">K., </span>
   <span class="font10">MET, </span>
   <span class="font10">TYR, </span>
   <span class="font10">V-ATPase </span>
   <span class="font10">angiotensin-converting </span>
   <span class="font10">between </span>
   <span class="font10">compounds </span>
   <span class="font10">font-size </span>
   <span class="font10">from </span>
   <span class="font10">inhibitor </span>
   <span class="font10">inhibitors </span>
   <span class="font10">interactions </span>
   <span class="font10">its </span>
   <span class="font10">potential </span>
   <span class="font10">proposed </span>
   <span class="font10">proteases </span>
   <span class="font10">residues </span>
   <span class="font10">studies </span>
   <span class="font10">their </span>
   <span class="font10">toxicity </span>
   <span class="font10">which </span>
   <span class="font10">(A) </span>
   <span class="font10">(B) </span>
   <span class="font10">(C) </span>
   <span class="font10">(D) </span>
   <span class="font10">(F) </span>
   <span class="font10">(Table </span>
   <span class="font10">ADMET </span>
   <span class="font10">AMP-dependent </span>
   <span class="font10">Chemistry, </span>
   <span class="font10">HIS, </span>
   <span class="font10">L., </span>
   <span class="font10">Leu, </span>
   <span class="font10">Moreover, </span>
   <span class="font10">Oseltamivir, </span>
   <span class="font10">P-glycoprotein </span>
   <span class="font10">SARS </span>
   <span class="font10">SARS-CoV- </span>
   <span class="font10">Tyr, </span>
   <span class="font10">azithromycin </span>
   <span class="font10">cellular </span>
   <span class="font10">cyclic </span>
   <span class="font10">distribution </span>
   <span class="font10">double; </span>
   <span class="font10">drugs. </span>
   <span class="font10">indicated </span>
   <span class="font10">key </span>
   <span class="font10">lopinavir </span>
   <span class="font10">low </span>
   <span class="font10">membrane </span>
   <span class="font10">observed </span>
   <span class="font10">proteins </span>
   <span class="font10">site </span>
   <span class="font10">study </span>
   <span class="font10">virus </span>
   <span class="font10">Azithromycin, </span>
   <span class="font10">B., </span>
   <span class="font10">Biochemistry, </span>
   <span class="font10">CYPA </span>
   <span class="font10">His </span>
   <span class="font10">His, </span>
   <span class="font10">Predicted </span>
   <span class="font10">R., </span>
   <span class="font10">Research, </span>
   <span class="font10">Ribavirin. </span>
   <span class="font10">This </span>
   <span class="font10">affinity </span>
   <span class="font10">analysis </span>
   <span class="font10">antiviral </span>
   <span class="font10">based </span>
   <span class="font10">border-color </span>
   <span class="font10">border-width </span>
   <span class="font10">cAMP-PKA </span>
   <span class="font10">chloroquine, </span>
   <span class="font10">coronavirus. </span>
   <span class="font10">fusion </span>
   <span class="font10">hydrogen </span>
   <span class="font10">inhibitior </span>
   <span class="font10">like </span>
   <span class="font10">lipophilicity </span>
   <span class="font10">main </span>
   <span class="font10">papain-like </span>
   <span class="font10">promiscuity </span>
   <span class="font10">putative </span>
   <span class="font10">replication </span>
   <span class="font10">reported </span>
   <span class="font10">repurposing </span>
   <span class="font10">results </span>
   <span class="font10">selected </span>
   <span class="font10">shown </span>
   <span class="font10">sites </span>
   <span class="font10">solid; </span>
   <span class="font10">substrate </span>
   <span class="font10">such </span>
   <span class="font10">syndrome </span>
   <span class="font10">transporter </span>
   <span class="font10">view </span>
   <span class="font10">{font-style </span>
   <span class="font10">{font-weight </span>
   <span class="font10">(E) </span>
   <span class="font10">(Figure </span>
   <span class="font10">ALA, </span>
   <span class="font10">ASN, </span>
   <span class="font10">ATPase </span>
   <span class="font10">Biological </span>
   <span class="font10">C., </span>
   <span class="font10">CLpro </span>
   <span class="font10">CYP </span>
   <span class="font10">CYPC, </span>
   <span class="font10">Caco </span>
   <span class="font10">Chemical </span>
   <span class="font10">Department </span>
   <span class="font10">Drug </span>
   <span class="font10">East </span>
   <span class="font10">GLU, </span>
   <span class="font10">Infectious </span>
   <span class="font10">LYS, </span>
   <span class="font10">MM/GBSA </span>
   <span class="font10">Middle </span>
   <span class="font10">NHE </span>
   <span class="font10">O., </span>
   <span class="font10">Phe </span>
   <span class="font10">SER, </span>
   <span class="font10">THR, </span>
   <span class="font10">VAL, </span>
   <span class="font10">W., </span>
   <span class="font10">acute </span>
   <span class="font10">bold </span>
   <span class="font10">chemical </span>
   <span class="font10">complexes </span>
   <span class="font10">corresponding </span>
   <span class="font10">courier; </span>
   <span class="font10">dynamics </span>
   <span class="font10">effective </span>
   <span class="font10">elastic </span>
   <span class="font10">em; </span>
   <span class="font10">endocytic </span>
   <span class="font10">endosomal </span>
   <span class="font10">energies </span>
   <span class="font10">energy </span>
   <span class="font10">format </span>
   <span class="font10">functions </span>
   <span class="font10">high </span>
   <span class="font10">inhibition </span>
   <span class="font10">inhibitory </span>
   <span class="font10">involved </span>
   <span class="font10">least </span>
   <span class="font10">ligands </span>
   <span class="font10">lumen </span>
   <span class="font10">map </span>
   <span class="font10">model </span>
   <span class="font10">motion </span>
   <span class="font10">nervous </span>
   <span class="font10">not </span>
   <span class="font10">oseltamivir, </span>
   <span class="font10">out </span>
   <span class="font10">pharmacokinetic </span>
   <span class="font10">plasma </span>
   <span class="font10">pocket </span>
   <span class="font10">presented </span>
   <span class="font10">protease. </span>
   <span class="font10">proton-translocating </span>
   <span class="font10">pt;} </span>
   <span class="font10">relatively </span>
   <span class="font10">species </span>
   <span class="font10">structures </span>
   <span class="font10">system </span>
   <span class="font10">this </span>
   <span class="font10">tool </span>
   <span class="font10">treatment </span>
   <span class="font10">vacuolar </span>
   <span class="font10">via </span>
   <span class="font10">vivo </span>
  </p>
 </body>
</html>
